# Valproate Sodium

## Depakine inj 400mg

| TAH Drug Code      | [IDEP4](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IDEP4)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Epilepsy that cannot be controlled by oral routes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Dosing             | Seizures unable to use oral form valproic acid: Total daily IV dose should be equivalent to the total daily oral valproate dose (expressed as valproic acid) and divided every 6 hours. Administer each dose as a 60-minute infusion (rate 20 mg/minute). Start intravenous administration 4 to 6 hours after the last oral administration. The original oral dose (usually an average dose of 20 to 30 mg/kg/day) can be administered by drip for 24 hours. To achieve therapeutic levels of valproic acid quickly: initially give 15 mg/kg by a slow intravenous injection (> 5 minutes), followed by 1 mg/kg/hour intravenous continuous infusion, and adjust the dose according to target serum level and clinical symptoms.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Hypersensitivity to valproate sodium. Hepatic disease or significant hepatic dysfunction. Use in patients with mitochondrial disorders caused by mutations in mitochondrial DNA polymerase gamma (POLG; eg, Alpers-Huttenlocher syndrome) and in children younger than 2 years with a suspected POLG-related disorder. For prevention of migraine headaches in pregnant women and in women of childbearing potential who are not using effective contraception. Urea cycle disorders. Concomitant use with mefloquine or St.-John's-Wort. Patients with systemic primary carnitine deficiency whose blood levels of hypocarnitinemia have not been corrected.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Adverse Effects    | >10%: Dermatologic: Alopecia (6-24%) Gastrointestinal: Abdominal pain (1%), anorexia (4-12%), diarrhea (<1%), dyspepsia (7-23%), nausea (3-6%), vomiting (1%) Hematologic & oncologic: Thrombocytopenia (1-27%) Infection: Infection (12-20%) Nervous system: Asthenia (7%), dizziness (5-7%), drowsiness (2-11%), headache (3-4%), insomnia (9-15%), nervousness (<1%), pain (1%), tremor (<1%) Ophthalmic: Diplopia (16%), visual disturbance (4-12%) Respiratory: Flu-like symptoms (12%) Miscellaneous: Accidental injury (6-11%) 1-10%: Cardiovascular: Cardiac arrhythmia (>1%), chest pain (2%), edema (1-5%), hypertension (1-5%), hypotension (1-5%), orthostatic hypotension (1-5%), palpitations (1-5%), peripheral edema (3-8%), tachycardia (1-5%), vasodilation (<1%) Dermatologic: Diaphoresis (<1%), ecchymoses (1-5%), erythema nodosum (>1%), furunculosis (1-5%), maculopapular rash (1-5%), pruritus (1-5%), seborrhea (1-5%), skin rash (6%), vesiculobullous dermatitis (>1%), xeroderma (1-5%) Endocrine & metabolic: Amenorrhea (1-5%), weight gain (4-9%), weight loss (6%) Gastrointestinal: Constipation (1-5%), dysgeusia (2%), dysphagia (>1%), eructation (1-5%), fecal incontinence (1-5%), flatulence (1-5%), gastroenteritis (1-5%), gingival hemorrhage (>1%), glossitis (1-5%), hematemesis (1-5%), hiccups (>1%), increased appetite (6%), oral mucosa ulcer (>1%), pancreatitis (1-5%), periodontal abscess (1-5%), stomatitis (1-5%), xerostomia (1-5%) Genitourinary: Cystitis (1-5%), dysmenorrhea (1-5%), dysuria (1-5%), urinary frequency (1-5%), urinary incontinence (1-5%), urinary tract infection (>1%), vaginal hemorrhage (1-5%), vaginitis (1-5%) Hematologic & oncologic: Anemia (>1%), hypoproteinemia (>1%), leukopenia (>1%), petechia (1-5%), prolonged bleeding time (>1%) Hepatic: Increased serum alanine aminotransferase (1-5%), increased serum aspartate aminotransferase (1-5%) Hypersensitivity: Facial edema (1-5%) Infection: Fungal infection (>1%), viral infection (1-5%) Local: Injection-site reaction (2%), pain at injection site (3%) Nervous system: Abnormal dreams (1-5%), abnormal gait (1-5%), agitation (1-5%), amnesia (4-7%), anxiety (1-5%), ataxia (8%), catatonia (1-5%), changes in thinking (6%), chills (1-5%), confusion (1-5%), depression (1-5%), dysarthria (1-5%), emotional lability (6%), hallucination (1-5%), hyperreflexia (1-5%), hypertonia (1-5%), malaise (1-5%), myasthenia (1-5%), paresthesia (<=7%), personality disorder (1-5%), psychosis (>1%), sleep disturbance (>1%), speech disturbance (1-5%), twitching (1-5%), vertigo (1-5%) Neuromuscular & skeletal: Arthralgia (1-5%), back pain (8%), discoid lupus erythematosus (1-5%), hypokinesia (1-5%), lower limb cramp (1-5%), myalgia (1-5%), neck pain (1-5%), neck stiffness (1-5%), osteoarthritis (1-5%), tardive dyskinesia (1-5%) Ophthalmic: Conjunctivitis (1-5%), dry eye syndrome (1-5%), eye pain (1-5%), nystagmus disorder (1-8%), photophobia (>1%) Otic: Deafness (1-5%), otitis media (1-5%), tinnitus (1-7%) Respiratory: Bronchitis (5%), cough (1-5%), dyspnea (1-5%), epistaxis (1-5%), pharyngitis (<1%), pneumonia (1-5%), rhinitis (1-5%), sinusitis (1-5%) Miscellaneous: Fever (6%) <1%: Nervous system: Euphoria, hypoesthesia Frequency not defined (any formulation): Nervous system: Suicidal ideation, suicidal tendencies Postmarketing: Cardiovascular: Bradycardia Dermatologic: Acute generalized exanthematous pustulosis, changes of hair (color, texture), erythema multiforme, erythroderma, hyperpigmentation, nail bed changes, nail disease, psoriasiform eruption, skin photosensitivity, Stevens-Johnson syndrome, toxic epidermal necrolysis 下略 |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/valproate-valproic-acid-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

## Depakine oral solution 200mg/mL, 40mL

| TAH Drug Code      | [LDEP](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=LDEP)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Epilepsy including grand mal, petit mal, mixed and temporal lobe epilepsy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Dosing             | Giving with food to decrease gastrointestinal irritation. Children 6 years and below: syrup or oral liquid is recommended for administration. DEPAKINE 500mg Chrono Tablet is only recommended for adult and children > 17 kg. Average daily dose (per 24 hours): Adult and adolescents: 20-30 mg/kg/day in 2 or 3 divided doses. Children: 30 mg/kg/day in 2 or 3 divided doses. (< 1 year old: in 2 divided doses)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Hypersensitivity to valproate sodium. Hepatic disease or significant hepatic dysfunction. Use in patients with mitochondrial disorders caused by mutations in mitochondrial DNA polymerase gamma (POLG; eg, Alpers-Huttenlocher syndrome) and in children younger than 2 years with a suspected POLG-related disorder. For prevention of migraine headaches in pregnant women and in women of childbearing potential who are not using effective contraception. Urea cycle disorders. Concomitant use with mefloquine or St.-John's-Wort. Patients with systemic primary carnitine deficiency whose blood levels of hypocarnitinemia have not been corrected.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | >10%: Dermatologic: Alopecia (6-24%) Gastrointestinal: Abdominal pain (7-23%), anorexia (4-12%), diarrhea (7-23%), dyspepsia (7-23%), nausea (15-48%), vomiting (7-27%) Hematologic & oncologic: Thrombocytopenia (1-27%) Infection: Infection (12-20%) Nervous system: Asthenia (6-27%), dizziness (12-25%), drowsiness (7-30%), headache (31%), insomnia (9-15%), nervousness (7-11%), pain (11%), tremor (9-57%) Ophthalmic: Diplopia (16%), visual disturbance (4-12%) Respiratory: Flu-like symptoms (12%) Miscellaneous: Accidental injury (6-11%) 1% to 10%: Cardiovascular: Cardiac arrhythmia (>1%), chest pain (2%), edema (1-5%), hypertension (1-5%), hypotension (1-5%), orthostatic hypotension (1-5%), palpitations (1-5%), peripheral edema (3-8%), tachycardia (1-5%), vasodilation (1-5%) Dermatologic: Diaphoresis (>1%), ecchymoses (1-5%), erythema nodosum (>1%), furunculosis (1-5%), maculopapular rash (1-5%), pruritus (1-5%), seborrhea (1-5%), skin rash (6%), vesiculobullous dermatitis (>1%), xeroderma (1-5%) Endocrine & metabolic: Amenorrhea (1-5%), weight gain (4-9%), weight loss (6%) Gastrointestinal: Constipation (1-5%), dysgeusia (2%), dysphagia (>1%), eructation (1-5%), fecal incontinence (1-5%), flatulence (1-5%), gastroenteritis (1-5%), gingival hemorrhage (>1%), glossitis (1-5%), hematemesis (1-5%), hiccups (>1%), increased appetite (6%), oral mucosa ulcer (>1%), pancreatitis (1-5%), periodontal abscess (1-5%), stomatitis (1-5%), xerostomia (1-5%) Genitourinary: Cystitis (1-5%), dysmenorrhea (1-5%), dysuria (1-5%), urinary frequency (1-5%), urinary incontinence (1-5%), urinary tract infection (>1%), vaginal hemorrhage (1-5%), vaginitis (1-5%) Hematologic & oncologic: Anemia (>1%), hypoproteinemia (>1%), leukopenia (>1%), petechia (1-5%), prolonged bleeding time (>1%) Hepatic: Increased serum alanine aminotransferase (1-5%), increased serum aspartate aminotransferase (1-5%) Hypersensitivity: Facial edema (1-5%) Infection: Fungal infection (>1%), viral infection (1-5%) Nervous system: Abnormal dreams (1-5%), abnormal gait (1-5%), agitation (1-5%), amnesia (4-7%), anxiety (1-5%), ataxia (8%), catatonia (1-5%), changes in thinking (6%), chills (1-5%), confusion (1-5%), depression (1-5%), dysarthria (1-5%), emotional lability (6%), hallucination (1-5%), hyperreflexia (1-5%), hypertonia (1-5%), malaise (1-5%), myasthenia (1-5%), paresthesia (<=7%), personality disorder (1-5%), psychosis (>1%), sleep disturbance (>1%), speech disturbance (1-5%), twitching (1-5%), vertigo (1-5%) Neuromuscular & skeletal: Arthralgia (1-5%), back pain (8%), discoid lupus erythematosus (1-5%), hypokinesia (1-5%), lower limb cramp (1-5%), myalgia (1-5%), neck pain (1-5%), neck stiffness (1-5%), osteoarthritis (1-5%), tardive dyskinesia (1-5%) Ophthalmic: Conjunctivitis (1-5%), dry eye syndrome (1-5%), eye pain (1-5%), nystagmus disorder (1-8%), photophobia (>1%) Otic: Deafness (1-5%), otitis media (1-5%), tinnitus (1-7%) Respiratory: Bronchitis (5%), cough (1-5%), dyspnea (1-5%), epistaxis (1-5%), pharyngitis (2-8%), pneumonia (1-5%), rhinitis (1-5%), sinusitis (1-5%) Miscellaneous: Fever (6%) Postmarketing: Cardiovascular: Bradycardia Dermatologic: Acute generalized exanthematous pustulosis, changes of hair (color, texture), erythema multiforme, erythroderma, hyperpigmentation, nail bed changes, nail disease, psoriasiform eruption, skin photosensitivity, Stevens-Johnson syndrome, toxic epidermal necrolysis 下略 |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| More Info          | [UpToDate](https://www.uptodate.com/contents/valproate-valproic-acid-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

## Depakine 200mg

| TAH Drug Code      | [ODEP2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ODEP2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Generalized and localized epilepsy, childhood convulsions or childhood febrile convulsions, behavioral disorders accompanied by epilepsy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Dosing             | Giving with food to decrease gastrointestinal irritation. Children 6 years and below: syrup or oral liquid is recommended for administration. DEPAKINE 500mg Chrono Tablet is only recommended for adult and children > 17 kg. Average daily dose (per 24 hours): Adult and adolescents: 20-30 mg/kg/day in 2 or 3 divided doses. Children: 30 mg/kg/day in 2 or 3 divided doses. (< 1 year old: in 2 divided doses)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Hypersensitivity to valproate sodium. Hepatic disease or significant hepatic dysfunction. Use in patients with mitochondrial disorders caused by mutations in mitochondrial DNA polymerase gamma (POLG; eg, Alpers-Huttenlocher syndrome) and in children younger than 2 years with a suspected POLG-related disorder. For prevention of migraine headaches in pregnant women and in women of childbearing potential who are not using effective contraception. Urea cycle disorders. Concomitant use with mefloquine or St.-John's-Wort. Patients with systemic primary carnitine deficiency whose blood levels of hypocarnitinemia have not been corrected.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | >10%: Dermatologic: Alopecia (6-24%) Gastrointestinal: Abdominal pain (7-23%), anorexia (4-12%), diarrhea (7-23%), dyspepsia (7-23%), nausea (15-48%), vomiting (7-27%) Hematologic & oncologic: Thrombocytopenia (1-27%) Infection: Infection (12-20%) Nervous system: Asthenia (6-27%), dizziness (12-25%), drowsiness (7-30%), headache (31%), insomnia (9-15%), nervousness (7-11%), pain (11%), tremor (9-57%) Ophthalmic: Diplopia (16%), visual disturbance (4-12%) Respiratory: Flu-like symptoms (12%) Miscellaneous: Accidental injury (6-11%) 1% to 10%: Cardiovascular: Cardiac arrhythmia (>1%), chest pain (2%), edema (1-5%), hypertension (1-5%), hypotension (1-5%), orthostatic hypotension (1-5%), palpitations (1-5%), peripheral edema (3-8%), tachycardia (1-5%), vasodilation (1-5%) Dermatologic: Diaphoresis (>1%), ecchymoses (1-5%), erythema nodosum (>1%), furunculosis (1-5%), maculopapular rash (1-5%), pruritus (1-5%), seborrhea (1-5%), skin rash (6%), vesiculobullous dermatitis (>1%), xeroderma (1-5%) Endocrine & metabolic: Amenorrhea (1-5%), weight gain (4-9%), weight loss (6%) Gastrointestinal: Constipation (1-5%), dysgeusia (2%), dysphagia (>1%), eructation (1-5%), fecal incontinence (1-5%), flatulence (1-5%), gastroenteritis (1-5%), gingival hemorrhage (>1%), glossitis (1-5%), hematemesis (1-5%), hiccups (>1%), increased appetite (6%), oral mucosa ulcer (>1%), pancreatitis (1-5%), periodontal abscess (1-5%), stomatitis (1-5%), xerostomia (1-5%) Genitourinary: Cystitis (1-5%), dysmenorrhea (1-5%), dysuria (1-5%), urinary frequency (1-5%), urinary incontinence (1-5%), urinary tract infection (>1%), vaginal hemorrhage (1-5%), vaginitis (1-5%) Hematologic & oncologic: Anemia (>1%), hypoproteinemia (>1%), leukopenia (>1%), petechia (1-5%), prolonged bleeding time (>1%) Hepatic: Increased serum alanine aminotransferase (1-5%), increased serum aspartate aminotransferase (1-5%) Hypersensitivity: Facial edema (1-5%) Infection: Fungal infection (>1%), viral infection (1-5%) Nervous system: Abnormal dreams (1-5%), abnormal gait (1-5%), agitation (1-5%), amnesia (4-7%), anxiety (1-5%), ataxia (8%), catatonia (1-5%), changes in thinking (6%), chills (1-5%), confusion (1-5%), depression (1-5%), dysarthria (1-5%), emotional lability (6%), hallucination (1-5%), hyperreflexia (1-5%), hypertonia (1-5%), malaise (1-5%), myasthenia (1-5%), paresthesia (<=7%), personality disorder (1-5%), psychosis (>1%), sleep disturbance (>1%), speech disturbance (1-5%), twitching (1-5%), vertigo (1-5%) Neuromuscular & skeletal: Arthralgia (1-5%), back pain (8%), discoid lupus erythematosus (1-5%), hypokinesia (1-5%), lower limb cramp (1-5%), myalgia (1-5%), neck pain (1-5%), neck stiffness (1-5%), osteoarthritis (1-5%), tardive dyskinesia (1-5%) Ophthalmic: Conjunctivitis (1-5%), dry eye syndrome (1-5%), eye pain (1-5%), nystagmus disorder (1-8%), photophobia (>1%) Otic: Deafness (1-5%), otitis media (1-5%), tinnitus (1-7%) Respiratory: Bronchitis (5%), cough (1-5%), dyspnea (1-5%), epistaxis (1-5%), pharyngitis (2-8%), pneumonia (1-5%), rhinitis (1-5%), sinusitis (1-5%) Miscellaneous: Fever (6%) Postmarketing: Cardiovascular: Bradycardia Dermatologic: Acute generalized exanthematous pustulosis, changes of hair (color, texture), erythema multiforme, erythroderma, hyperpigmentation, nail bed changes, nail disease, psoriasiform eruption, skin photosensitivity, Stevens-Johnson syndrome, toxic epidermal necrolysis 下略 |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| More Info          | [UpToDate](https://www.uptodate.com/contents/valproate-valproic-acid-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

## DEPAKINE 500mg

| TAH Drug Code      | [ODEP5](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ODEP5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Grand mal, petit mal, mixed and temporal lobe epilepsy of epilepsy; mania.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Dosing             | Epilepsy: Adult and children > 17 kg: Initially 10-15 mg/kg/day ,then increase to the appropriate dose: 20-30 mg/kg/day in 1-2 divided doses. When epilepsy is not controlled or side effects are suspected, the blood concentration of valproic acid can be used for clinical follow-up. The effective therapeutic concentration is usually between 40-100 mg/L (280 to 700 μmol/L). Mania: Initially 600 mg daily increasing by 200 mg/day every 3 days to reach desired clinical effect. Usual dose range: 1000-2000 mg/day (20-30 mg/kg/day) Dose may be further increased to maximum 2500 mg/day if necessary.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Hypersensitivity to valproate sodium. Hepatic disease or significant hepatic dysfunction. Use in patients with mitochondrial disorders caused by mutations in mitochondrial DNA polymerase gamma (POLG; eg, Alpers-Huttenlocher syndrome) and in children younger than 2 years with a suspected POLG-related disorder. For prevention of migraine headaches in pregnant women and in women of childbearing potential who are not using effective contraception. Urea cycle disorders. Concomitant use with mefloquine or St.-John's-Wort. Patients with systemic primary carnitine deficiency whose blood levels of hypocarnitinemia have not been corrected.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | >10%: Dermatologic: Alopecia (6-24%) Gastrointestinal: Abdominal pain (7-23%), anorexia (4-12%), diarrhea (7-23%), dyspepsia (7-23%), nausea (15-48%), vomiting (7-27%) Hematologic & oncologic: Thrombocytopenia (1-27%) Infection: Infection (12-20%) Nervous system: Asthenia (6-27%), dizziness (12-25%), drowsiness (7-30%), headache (31%), insomnia (9-15%), nervousness (7-11%), pain (11%), tremor (9-57%) Ophthalmic: Diplopia (16%), visual disturbance (4-12%) Respiratory: Flu-like symptoms (12%) Miscellaneous: Accidental injury (6-11%) 1% to 10%: Cardiovascular: Cardiac arrhythmia (>1%), chest pain (2%), edema (1-5%), hypertension (1-5%), hypotension (1-5%), orthostatic hypotension (1-5%), palpitations (1-5%), peripheral edema (3-8%), tachycardia (1-5%), vasodilation (1-5%) Dermatologic: Diaphoresis (>1%), ecchymoses (1-5%), erythema nodosum (>1%), furunculosis (1-5%), maculopapular rash (1-5%), pruritus (1-5%), seborrhea (1-5%), skin rash (6%), vesiculobullous dermatitis (>1%), xeroderma (1-5%) Endocrine & metabolic: Amenorrhea (1-5%), weight gain (4-9%), weight loss (6%) Gastrointestinal: Constipation (1-5%), dysgeusia (2%), dysphagia (>1%), eructation (1-5%), fecal incontinence (1-5%), flatulence (1-5%), gastroenteritis (1-5%), gingival hemorrhage (>1%), glossitis (1-5%), hematemesis (1-5%), hiccups (>1%), increased appetite (6%), oral mucosa ulcer (>1%), pancreatitis (1-5%), periodontal abscess (1-5%), stomatitis (1-5%), xerostomia (1-5%) Genitourinary: Cystitis (1-5%), dysmenorrhea (1-5%), dysuria (1-5%), urinary frequency (1-5%), urinary incontinence (1-5%), urinary tract infection (>1%), vaginal hemorrhage (1-5%), vaginitis (1-5%) Hematologic & oncologic: Anemia (>1%), hypoproteinemia (>1%), leukopenia (>1%), petechia (1-5%), prolonged bleeding time (>1%) Hepatic: Increased serum alanine aminotransferase (1-5%), increased serum aspartate aminotransferase (1-5%) Hypersensitivity: Facial edema (1-5%) Infection: Fungal infection (>1%), viral infection (1-5%) Nervous system: Abnormal dreams (1-5%), abnormal gait (1-5%), agitation (1-5%), amnesia (4-7%), anxiety (1-5%), ataxia (8%), catatonia (1-5%), changes in thinking (6%), chills (1-5%), confusion (1-5%), depression (1-5%), dysarthria (1-5%), emotional lability (6%), hallucination (1-5%), hyperreflexia (1-5%), hypertonia (1-5%), malaise (1-5%), myasthenia (1-5%), paresthesia (<=7%), personality disorder (1-5%), psychosis (>1%), sleep disturbance (>1%), speech disturbance (1-5%), twitching (1-5%), vertigo (1-5%) Neuromuscular & skeletal: Arthralgia (1-5%), back pain (8%), discoid lupus erythematosus (1-5%), hypokinesia (1-5%), lower limb cramp (1-5%), myalgia (1-5%), neck pain (1-5%), neck stiffness (1-5%), osteoarthritis (1-5%), tardive dyskinesia (1-5%) Ophthalmic: Conjunctivitis (1-5%), dry eye syndrome (1-5%), eye pain (1-5%), nystagmus disorder (1-8%), photophobia (>1%) Otic: Deafness (1-5%), otitis media (1-5%), tinnitus (1-7%) Respiratory: Bronchitis (5%), cough (1-5%), dyspnea (1-5%), epistaxis (1-5%), pharyngitis (2-8%), pneumonia (1-5%), rhinitis (1-5%), sinusitis (1-5%) Miscellaneous: Fever (6%) Postmarketing: Cardiovascular: Bradycardia Dermatologic: Acute generalized exanthematous pustulosis, changes of hair (color, texture), erythema multiforme, erythroderma, hyperpigmentation, nail bed changes, nail disease, psoriasiform eruption, skin photosensitivity, Stevens-Johnson syndrome, toxic epidermal necrolysis 下略 |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| More Info          | [UpToDate](https://www.uptodate.com/contents/valproate-valproic-acid-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

